Literature DB >> 33453591

The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey.

Colin Reilly1, Amy Muggeridge2, J Helen Cross3.   

Abstract

PURPOSE: To garner the views of young people with epilepsy and caregivers regarding the impact of COVID-19 and subsequent restrictions in the UK. MEHODS: An online survey was used to explore the views of young people with epilepsy (n = 71) and caregivers (n = 130) in June 2020. It included questions on the impact of the pandemic and associated restrictions on the child's epilepsy and on child and parental wellbeing.
RESULTS: One in three young people and 29 % of caregivers reported that the young person's seizures had increased during the pandemic (only 10 % of young people and 8% of caregivers reported a decrease). Half of young people reported that they were more reluctant to go to hospital. Thirty-one percent of young people and 20 % of parents reported difficulties getting epilepsy medication whilst a significant minority of young people (18 %) and caregivers (25 %) reported that the young person had investigations/assessments cancelled by their hospital. The majority of young people reported their sleep (72 %), mood (64 %) and levels of physical activity (53 %) had deteriorated. Caregivers experienced increases in stress (55 %) and anxiety (52 %). Epilepsy nurses were seen as the most helpful support
CONCLUSIONS: Results indicate that the pandemic and associated restrictions have had a negative impact on young people with epilepsy. Perceived increases in seizures, reluctance to go to hospital and cancelled investigations are likely to impact on epilepsy management. The wider psychosocial impact is also likely to be significant with increases in child and caregiver mental health problems in an already vulnerable group.
Copyright © 2021 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behaviour; COVID-19; Epilepsy; Sleep

Mesh:

Year:  2021        PMID: 33453591      PMCID: PMC7791316          DOI: 10.1016/j.seizure.2020.12.024

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


Introduction

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is having a profound effect on all societies. It has resulted in tens of millions of infections and over 1 million deaths worldwide (https://covid19.who.int/ accessed 19th October 2020). Countries have taken unprecedented steps to respond to the public health threat posed by the pandemic. In the UK the government imposed a range of restrictions in late March 2020 including a directive to stay at home except for essential purchases, essential work or medical needs. Physical exercise outside the home was limited and schools were closed for the majority of children. In response to COVID-19, the use of telemedicine has increased significantly [1]. Care for young people with epilepsy has also changed dramatically including use of increased telemedicine, decreased EEG use, and in some cases cessation or limiting of epilepsy surgery [2]. To date there is limited evidence to suggest that COVID-19 can directly affect seizures but there is evidence that the COVID-19 pandemic has resulted in increased psychological distress among individuals with epilepsy [3]. Increased stress can be associated with increased seizures [4]. In addition to seizures, many young people with epilepsy are at increased risk for mental health and behavioural problems [6]. Thus in the context of the COVID-19 pandemic and associated restrictions, young people with epilepsy are likely to be a particularly vulnerable group with respect to the development of, or exacerbation of existing mental health and behaviour difficulties. To date there has been very limited research on the views and experiences of young people with epilepsy regarding the impact of COVID-19 pandemic and subsequent restrictions. The aim of the current study was to garner the views and experiences of young people with epilepsy and caregivers regarding the impact of the pandemic in the UK.

Methodology

An anonymous online survey hosted on Survey Monkey was used to explore the views of young people (n = 71) with epilepsy and caregivers (n = 130) resident in the UK between May and June 2020. The surveys were accessible online and publicised online via social media (Twitter, Facebook, Instagram) by the Young Epilepsy Charity. For the purposes of the current study young people were considered to be aged between 0 and 25 years. There were two separate surveys - one for young people with epilepsy and one for caregivers for people with epilepsy with similar questions. ‘Caregiver’ was defined as the person primarily responsible for the child’s care. The surveys were developed and piloted in collaboration with a small group of young people with epilepsy and their caregivers in April 2020. The surveys included questions on the potential impact of Covid-19 and restrictions on the young person with epilepsy and on young person and caregiver wellbeing (see supplement 1).

Analysis

Characteristics of participating people with epilepsy and their caregivers and responses to survey items were analysed in terms of frequencies and means and are reported as descriptive statistics. All data was analysed in IBM SPSS version 25.

Ethics

As a charity anonymysed survey, formal ethical review and approval was not required for the study. It was written by experienced childhood epilepsy researchers and approved by the Research Governance and Strategy Board at Young Epilepsy (operating name for The National Centre for Young People with Epilepsy). Written informed consent was implied via the completion of the questionnaire.

Results

The characteristics of the young people with epilepsy (n = 71) and caregivers (n = 130) who responded to the survey are shown are shown in Table 1 .
Table 1

Characteristics of respondents to Corona Virus survey.

Young people with Epilepsy survey (n = 71)Caregiver survey (n = 130)
Age of young personRange 12−25 yearsMean 20.76SD 3.482Range 0−25 yearsMean 8.88SD 5.515
Gender of person with epilepsy
Female61 (86)64 (49%)
Male10 (14%)66 (51%)
Gender of Caregivers
FemaleN/A128 (98%)
MaleN/A2 (2%)
Learning/behaviorOne or more neurodevelopmental, learning or mental health problem51 (72%)63 (48%)
Age of diagnosis of epilepsyRange 0.17−24yearsMean12.04SD 5.380−18 yearsMean 5.13SD 4.13
Duration of Epilepsy0−22 yearsMean = 8.89 yearsSD 5.820−25 yearsMean 3.75SD 4.57
Anti-seizure Medications
None2 (3%)6 (5%)
One29 (41%)65 (50%)
Two26 (37%)32 (25%)
Three or more12 (17%)27 (21%)
Don’t Know2 (3%)0 (0%)
Emergency medication
Yes28 (39%)
No41 (58%)73 (56%)
Not known2 (3%)57 (44%)
Characteristics of respondents to Corona Virus survey. The views of young people with epilepsy and caregivers regarding aspects of their epilepsy, epilepsy care and wellbeing during the pandemic are in Table 2 .
Table 2

Perceptions of epilepsy, epilepsy care and wellbeing during pandemic and associated restrictions.

Seizure frequency during pandemicYoung Person with Epilepsy (n = 71)Caregiver (n = 130)
Difficult to say if has changeda17 (24%)33 (26%)
Not changed23 (32%)48 (37%)
Yes, decreased7 (10%)10 (8%)
Yes, increased24 (34%)38 (29%)
Difficulties accessing medicine during pandemicb
No49 (69%)103 (80%)
Yes22 (31%)25 (20%)
Access to epilepsy doctor/epilepsy nurse during pandemic
No changeb30 (42%)47 (37%)
Negative changes26 (37%)51 (40%)
Positive changes15 (21%)30 (23%)
Cancellations of medical appointments during pandemic and reluctance to go hospital
Investigations Cancelled by hospitalc13 (18%)32 (25%)
Investigations Cancelled by patientc12 (17%)12 (10%)
Reluctant to go/take PWE to hospitald,e31 (49%)83 (66%)
Telehealth replaced hospital visits during pandemic
With Doctor18 (25%)68 (52%)
With nurse26 (37%)43 (33%)
Satisfaction with telehealth during pandemicf,g
Same level of satisfaction22 (59%)56 (63%)
Less satisfied than usual10 (27%)20 (23%)
More satisfied than usual5 (14%)12 (14%)
Most helpful source of support during pandemic
Doctor7 (10%)26 (20%)
Epilepsy nurse22 (31%)45 (35%)
Online support group14 (20%)40 (31%)
NHS websites16 (23%)7 (5%)
Epilepsy charity websites19 (24%)14 (11%)
Not found anything helpful I trust10 (14%)18 (14%)
I have not needed help/support7 (10%)22 (17%)
Impact of lockdown on young person with epilepsy
Behaviourh, i
 Better8 (14%)26 (25%)
 Worse21 (36 %)53 (51%)
 Not affected30 (51%)36 (34%)
Moodh,i
 Better8 (14%)15 (14%)
 Worse38 (64%)64 (61%)
 Not affected13 (22%)26 (25%)
Sleep h,i
 Better5 (8%)17 (16%)
 Worse43 (72%)59 (56%)
 Not affected11 (17%)29 (28%)
Physical Activity h,j
 Better20 (34%)19 (18%)
 Worse31 (53%)65 (63%)
 Not affected8 (14%)20 (19%)
Perceived Impact of Coronavirus restrictions on the family
Negative Economic ImpactNA46 (35 %)
Increased caregiver stressNA72 (55 %)
More anxiousNA68 (52 %)
More depressedNA36 (28 %)
Worse sleepNA57(44 %)
Relationships with partner/spouseNA20 (15%)

Caregiver: an = 129 bn = 128 cn = 127 en = 126 gn = 88 in = 105 nj=104.

Young Person with epilepsy dn = 61 nf = 37 hn = 59 NA = not applicable.

Perceptions of epilepsy, epilepsy care and wellbeing during pandemic and associated restrictions. Caregiver: an = 129 bn = 128 cn = 127 en = 126 gn = 88 in = 105 nj=104. Young Person with epilepsy dn = 61 nf = 37 hn = 59 NA = not applicable.

Epilepsy and Epilepsy care during the pandemic

Thirty-four percent of young people with epilepsy and 29 % of caregivers felt that the young person’s seizures had increased compared with only 10 % and 8% respectively who perceived a decrease in seizure frequency. Thirty-one percent of young people with epilepsy and 20 % of caregivers reported difficulties accessing medicine during the pandemic. Regarding investigations (such as EEG or MRI), 18 % of young people and 25 % of caregivers reported that the hospital had cancelled investigations whilst 17 % of young people and 10 % of caregivers had themselves cancelled investigations. The majority of young people and caregivers reported the same level of satisfaction with telehealth compared with previous in-person consultations. However, a significant minority of young people with epilepsy (27 %) and caregivers (23 %) were less satisfied with telehealth compared to usual in-person consultations.

Perceptions of support and impact of lockdown young person and caregiver wellbeing

For young people with epilepsy and caregivers, epilepsy specialist nurses were identified most often as the best source of support. The majority of young people and caregivers reported that the young person’s mood and sleep had worsened since the introduction of COVID-19 restrictions. Additionally, the majority of caregivers reported increased anxiety, stress and worse sleep as a result of the pandemic.

Discussion

Many young people with epilepsy and caregivers perceived the COVID-19 pandemic and associated restrictions to have had a negative impact on epilepsy care and individual wellbeing. A minority reported increases in seizure frequency, difficulties accessing medicine, cancelled investigations and dissatisfaction with the telemedicine which had replaced in-person consultations. More young people and caregivers reported an increase in seizure frequency than reported a decrease. An Italian study of adults with epilepsy found that 18 % reported a seizure increase [6] whilst 8.5 % reported an increase in a Chinese study of adults [3]. In studies from Saudi Arabia and Spain where respondents were predominantly adults, 27 % and 29.5 % respectively reported an increase in seizure frequency [7,8]. A UK study reported that 19 % of respondents, which included adults with epilepsy and caregivers of both children and adults, reported a change in seizure frequency but it was not reported whether this was a decrease or increase [9]. The percentage of individuals who reported an increase in seizures in the current study is at the higher end of previous estimates and could reflect that the current study focusses on children and young adults as opposed to a predominately adult population. Differences could also reflect sampling methods employed and country specific aspects of COVID restrictions in the different studies. Difficulties accessing medicine, difficulties accessing epilepsy professionals and cancellations noted by some respondents in the current study have been previously reported [6]. All could impact seizure frequency. Increases could also be related to the reported increased stress, and problems with mood and sleep. The increased use of telehealth during the pandemic noted in the current study highlights the need to innovate; for many this maintained contact with their medical team. Moving forward, telehealth is likely to remain in delivery of care to people with epilepsy [10]. However it can have significant limitations including the confidence in the confidentiality of the medium used affecting communication regarding lifestyle habits [11]. The negative impact on epilepsy care provision for young people with epilepsy and dissatisfaction for some with telehealth, highlights the need to develop models of care tailored to the specific needs of children and young people. Thirty-five percent of respondents reported that investigations had been cancelled either by the hospital or by the person with epilepsy/caregiver. At the onset of the pandemic, many institutions stopped all elective work, with redeployment of staff to COVID treating areas. As services are reopened, with appropriate restrictions, waiting lists for elective procedures remain long. Stopping or limiting services required for care of chronic disease such as epilepsy is to the detriment of individuals concerned, and complete cessation of services is not the way forward when considering the likely longer term impact. Young people with epilepsy and caregivers noted that a significant of proportion of the young people with epilepsy experienced a deterioration in behavior, mood, anxiety and sleep. This is in line with a study in the general population which noted a deterioration of mental health during the pandemic [12]· Children and adults with epilepsy and caregivers are already at very high risk of mental health difficulties [5,13,14]and sleep difficulties. Thus it would appear that COVID-19 and associated restrictions exacerbates difficulties in an already vulnerable group. This exacerbation in mental health during the pandemic calls for integrated care for young people with epilepsy with health care providers needing to provide supports for not only epilepsy but also mental health [15]. The positive view of epilepsy specialist nurses in the pandemic suggest that they may be ideally placed to facilitate this integrated care where epilepsy specialist nurse services are available.

Limitations

An online survey method was used in the current study and it was not possible to estimate response rate and thus respondents may not be representative of the wider epilepsy population. We employed a bespoke non-validated questionnaire as opposed to standardised measures of emotional well-being and sleep. Use of seizure diaries may have provided more accurate data on changes in occurrence in seizures. The respondents to both the young people with epilepsy and caregiver survey were predominantly female and males may have different experiences. Because of the survey nature of the study we were not able to validate epilepsy diagnoses. The nature of questions and small subgroup sizes did not allow us to explore potential relationships between variables such as seizure frequency and mental health. Finally, not all questions were answered by all respondents.

Conclusion

Results indicate that the pandemic and associated restrictions have had a negative impact on many young people with epilepsy. Increases in seizure frequency and reluctance to go to hospital may impact on epilepsy management. The wider impact on young person and caregiver wellbeing is also likely to be significant due to increases in young person and caregiver mental health problems. There is a need to develop improved models of remote service delivery which focus not only on epilepsy but the wider psychosocial impact.

Funding

JHC is supported by the National Institute of Health Research (NIHR) Biomedical Research Centre at Great Ormond Street Hospital.

Declaration of Competing Interest

The authors have no other conflicts of interest to report.
  15 in total

1.  Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: Association with quality of life and stigma.

Authors:  Mario Tombini; Giovanni Assenza; Livia Quintiliani; Lorenzo Ricci; Jacopo Lanzone; Martina Ulivi; Vincenzo Di Lazzaro
Journal:  Epilepsy Behav       Date:  2020-04-19       Impact factor: 2.937

2.  Neurobehavioral comorbidities in children with active epilepsy: a population-based study.

Authors:  Colin Reilly; Patricia Atkinson; Krishna B Das; Richard F M C Chin; Sarah E Aylett; Victoria Burch; Christopher Gillberg; Rod C Scott; Brian G R Neville
Journal:  Pediatrics       Date:  2014-06       Impact factor: 7.124

Review 3.  Integrated care for childhood epilepsy: ongoing challenges and lessons for other long-term conditions.

Authors:  Amit Bali; Dougal S Hargreaves; John Cowman; Monica Lakhanpaul; Colin Dunkley; Millie Power; J Helen Cross
Journal:  Arch Dis Child       Date:  2016-05-24       Impact factor: 3.791

4.  The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy.

Authors:  Amal Alkhotani; Muhammad I Siddiqui; Fahad Almuntashri; Renad Baothman
Journal:  Epilepsy Behav       Date:  2020-07-14       Impact factor: 2.937

5.  Care Delivery for Children With Epilepsy During the COVID-19 Pandemic: An International Survey of Clinicians.

Authors:  Elaine C Wirrell; Zachary M Grinspan; Kelly G Knupp; Yuwu Jiang; Biju Hammeed; John R Mytinger; Anup D Patel; Rima Nabbout; Nicola Specchio; J Helen Cross; Renée A Shellhaas
Journal:  J Child Neurol       Date:  2020-07-15       Impact factor: 1.987

6.  Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population.

Authors:  Matthias Pierce; Holly Hope; Tamsin Ford; Stephani Hatch; Matthew Hotopf; Ann John; Evangelos Kontopantelis; Roger Webb; Simon Wessely; Sally McManus; Kathryn M Abel
Journal:  Lancet Psychiatry       Date:  2020-07-21       Impact factor: 27.083

Review 7.  Telehealth in pediatric epilepsy care: A rapid transition during the COVID-19 pandemic.

Authors:  Shifteh Sattar; Rachel Kuperman
Journal:  Epilepsy Behav       Date:  2020-07-28       Impact factor: 2.937

8.  Influence of the COVID-19 outbreak in people with epilepsy: Analysis of a Spanish population (EPICOVID registry).

Authors:  Alvaro Sanchez-Larsen; Esther Gonzalez-Villar; Inmaculada Díaz-Maroto; Almudena Layos-Romero; Álvaro Martínez-Martín; Cristian Alcahut-Rodriguez; Alberto Grande-Martin; David Sopelana-Garay
Journal:  Epilepsy Behav       Date:  2020-09-07       Impact factor: 2.937

9.  Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic.

Authors:  Francesco Brigo; Simona Bonavita; Letizia Leocani; Gioacchino Tedeschi; Luigi Lavorgna
Journal:  Epilepsy Behav       Date:  2020-05-15       Impact factor: 2.937

10.  COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy.

Authors:  Shanshan Huang; Chunmei Wu; Yuchao Jia; Guo Li; Zhou Zhu; Kai Lu; Yuyan Yang; Furong Wang; Suiqiang Zhu
Journal:  Epilepsia       Date:  2020-08-06       Impact factor: 5.864

View more
  8 in total

1.  Telemedicine in epilepsy management during the coronavirus disease 2019 pandemic.

Authors:  Kenjiro Kikuchi; Shin-Ichiro Hamano; Ayumi Horiguchi; Hazuki Nonoyama; Yuko Hirata; Ryuki Matsuura; Reiko Koichihara; Akira Oka; Daishi Hirano
Journal:  Pediatr Int       Date:  2022-01       Impact factor: 1.617

2.  Seizure control during the COVID-19 pandemic: Correlating Responsive Neurostimulation System data with patient reports.

Authors:  Cemal Karakas; Ryan Ward; Mohamed Hegazy; Henry Skrehot; Zulfi Haneef
Journal:  Clin Neurophysiol       Date:  2022-05-11       Impact factor: 4.861

3.  Resilience of adolescents and teenagers with self-limited and genetic-generalized epilepsy during the COVID-19 pandemic.

Authors:  Stephanie Kwok; Jennifer Engle; Anita N Datta
Journal:  Epilepsy Behav Rep       Date:  2021-12-25

4.  Levels of Depression and Anxiety Among Informal Caregivers During the COVID-19 Pandemic: A Study Based on the Canadian Longitudinal Study on Aging.

Authors:  Andrew Wister; Lun Li; Barbara Mitchell; Christina Wolfson; Jacqueline McMillan; Lauren E Griffith; Susan Kirkland; Parminder Raina
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-09-01       Impact factor: 4.942

5.  Impact of COVID-19 Pandemic on Children and Adolescents with Neuropsychiatric Disorders: Emotional/Behavioral Symptoms and Parental Stress.

Authors:  Francesca Felicia Operto; Giangennaro Coppola; Valentina Vivenzio; Chiara Scuoppo; Chiara Padovano; Valeria de Simone; Rosetta Rinaldi; Gilda Belfiore; Gianpiero Sica; Lucia Morcaldi; Floriana D'Onofrio; Miriam Olivieri; Serena Donadio; Michele Roccella; Marco Carotenuto; Andrea Viggiano; Grazia Maria Giovanna Pastorino
Journal:  Int J Environ Res Public Health       Date:  2022-03-23       Impact factor: 3.390

Review 6.  Changes in Healthcare Provision During Covid-19 and Their Impact on Children With Chronic Illness: A Scoping Review.

Authors:  Sapfo Lignou; Jenny Greenwood; Mark Sheehan; Ingrid Wolfe
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 1.730

7.  Seizure Control in Patients with Epilepsy during the COVID-19 Pandemic: A Systematic Review and Meta-analysis.

Authors:  Naoto Kuroda; Prasannakumar Kanubhai Gajera; Hongxuyang Yu; Takafumi Kubota
Journal:  Intern Med       Date:  2022-05-31       Impact factor: 1.282

8.  It's made a really hard situation even more difficult: The impact of COVID-19 on families of children with chronic illness.

Authors:  Jordana McLoone; Claire E Wakefield; Glenn M Marshall; Kristine Pierce; Adam Jaffe; Ann Bye; Sean E Kennedy; Donna Drew; Raghu Lingam
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.